Bank Of America Corp Codiak Bio Sciences, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.18 - $0.81 $806 - $3,631	4,483 Added 9.23%	53,055 $9,000
Q4 2022 Feb 10, 2023	BUY	$0.32 - $0.9 $10,885 - $30,614	34,016 Added 233.69%	48,572 $19,000
Q3 2022 Nov 14, 2022	BUY	$0.82 - $3.19 $11,814 - $45,961	14,408 Added 9735.14%	14,556 $11,000
Q2 2022 Aug 12, 2022	SELL	$2.24 - $6.96 $110,868 - $344,485	-49,495 Reduced 99.7%	148 $0
Q1 2022 May 16, 2022	BUY	$4.3 - $12.95 $176,338 - $531,066	41,009 Added 474.97%	49,643 $311,000
Q4 2021 Feb 08, 2022	BUY	$10.0 - $16.78 $15,170 - $25,455	1,517 Added 21.32%	8,634 $96,000
Q3 2021 Nov 15, 2021	BUY	$15.58 - $22.88 $44,480 - $65,322	2,855 Added 66.99%	7,117 $117,000
Q2 2021 Sep 13, 2021	BUY	$11.72 - $26.81 $49,950 - $114,264	4,262 New	4,262 $79,000

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.